Hummingbird Bioscience, Sanofi to develop novel cancer therapeutics
China | News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2016
Singapore: Hummingbird Bioscience, an innovative biotechnology company focused on the discovery and early development of...Read more
China's Ascentage Pharma joins hands with UNITY Biotechnology
China | News | By BioSpectrum Bureau | 0 Comment | 26 Apr, 2016
Singapore: China's clinical-stage biopharmaceutical company, Ascentage Pharma, announced collaboration with San Francisc...Read more
Chinese Ebola vaccine enters clinical trials
China | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2014
Singapore: According to a Chinese news agency, the country's regulators have approved a domestically developed experimen...Read more
Chinese drugs contain oil from restaurant drains
China | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: A recent report by the Chinese national media has claimed that gutter oil is being used to make antibiotics, ...Read more
CellSearch 'liquid biopsy' approved in China
China | News | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2012
Singapore: China State Food & Drug Administration (SFDA) has approved CellSearch, circulating tumor cell (CTC) test ...Read more
Pfizer invests $350 mn to build a biotech hub in China
China | News | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2016
Singapore: Global drug giant Pfizer has recently announced plans to invest $350 mn to build a Global Biotechnology Cente...Read more
GSK sells thrombosis brands to Aspen for $1.1 bn
China | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2013
Singapore: GlaxoSmithKline (GSK) has agreed to sell its thrombosis brands, Arixtra and Fraxiparine, and Notre-Dame de Bo...Read more
Cytori, Lorem to commercialize Cytori Cell Therapy
China | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2013
Singapore: US-based Cytori Therapeutics and China-based Lorem Vascular have formed a partnership to commercialize Cytori...Read more
Shanghai to host 'MEDTEC China 2014'
China | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2014
Singapore: With the objective to promote high-end medical equipment localization, China is holding MEDTEC China 2014 sum...Read more
MMR, UNIS join hands with Chinese government
China | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2013
Singapore: MMRGlobal announced that through its China joint venture, Unis-Tonghe MMR International Health Management Ser...Read more
Colorcon opens new lab in China
China | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2015
Singapore: US-based Colorcon, a world leader in offering development, supply and technical support to the pharmaceutical...Read more
China's Shanghai Pharma group to buy Australian Vitaco pharma
China | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2016
Singapore: Chinese drugmaker Shanghai Pharma and private equity firm Primavera capital recently announced their plans to...Read more
Biobanking has attractive prospects in Asia
China | Opinion | By BioSpectrum Bureau | 3 Comment | 12 Jun, 2012
Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attr...Read more
CPhI China to begin from June 21
China | News | By BioSpectrum Bureau | 0 Comment | 10 May, 2016
Singapore: Hosted by the UBM EMEA and CCCMHPIE and co-organised by UBM Sinoexpo, this year's CPhI China will be conducte...Read more
China Cord Blood, Cordlife join hands for stem cell therapy services
China | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2014
Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mo...Read more
China firm Beigene raises $75 mn
China | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014
Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...Read more
Johns Hopkins releases NCD policy briefs
China | Analysis | By BioSpectrum Bureau | 1 Comment | 05 Feb, 2013
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...Read more
Generon initiates phase I clinical study for F-652 in Australia
China | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein...Read more